TickerFactsScreenerDevelopers

Emmaus Life Sciences, Inc. (EMMA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $988.1K2010: $55.4K2011: $73.6K2012: $7.7K2013: $1.27M2014: $1.24M2015: $432.1K2016: $318.2K2017: $5.45M2018: $3.90M2019: $1.77M2020: $2.49M2021: $2.28M2022: $2.02M2023: $2.55M2024: $1.39M2025: $2.13M$2.13M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.13M+53.1%
2024$1.39M-45.5%
2023$2.55M+26.0%
2022$2.02M-11.3%
2021$2.28M-8.4%
2020$2.49M+40.6%
2019$1.77M-54.7%
2018$3.90M-28.3%
2017$5.45M+1612.4%
2016$318.2K-26.4%
2015$432.1K-65.2%
2014$1.24M-2.6%
2013$1.27M+16440.3%
2012$7.7K-89.5%
2011$73.6K+32.9%
2010$55.4K-94.4%
2009$988.1K—